1.Thyroid clear cell carcinoma: a case report.
Jing LIANG ; Su-sheng SHI ; Wei LUO ; Fu-sheng LIU
Chinese Journal of Oncology 2005;27(5):295-295
2.Clinical application of ERA resilient attachment in restoration of Kennedy Ⅰ dentition defect
Xiaoxia WU ; Zhen SHI ; Sheng LIN ; Xianmei ZHANG ; Yuxing SU ; Qian AN
Chinese Journal of Medical Aesthetics and Cosmetology 2009;15(1):31-33
Objective To investigate the effect of clinical application of ERA resilient attachment on Kennedy Ⅰ dentition defect. Methods Twenty-eight Kennedy Ⅰ dentition defect cases were restored by ERA resilient attachment dentures. After the examination of the function of the dentures, oral tissue, X-ray, the satisfaction to the dentures was evaluated. Results After the follow-up of 6 to 32 months, all the patients were satisfied with the dentures in esthetic, retention, normal function and healthy peri-odontium. Conclusion ERA resilient attachment is an esthetieal, economical and reliable approach to Kennedy Ⅰ dentition defect restoration.
3.Advance in studies of Panax notoginseng saponins on pharmacological mechanism of nervous system disease.
Ping SU ; Lei WANG ; Shi-Jing DU ; Wen-Feng XIN ; Wen-Sheng ZHANG
China Journal of Chinese Materia Medica 2014;39(23):4516-4521
The pharmacological mechaisms of Panax notoginseng saponins on nervous system diseases (Alzheimer's disease, Parkinson's disease, ischermic cerebral apoplexy and depressive disorder) , including panax notoginseng saponins, protoparaxotriol saponins, panasadiol saponins, ginsenoside Rg1, ginsenoside Rb1, ginsenoside Re and notoginsenoside R1 were summarized to analyze the study hotspots and potential advantages (such as estrogen-like effect) of notoginsenoside's pharmacological actions, provide reference for further pharmacological studies and new ideas for clinical treatment of nervous system diseases and drug studies and development.
Animals
;
Drugs, Chinese Herbal
;
administration & dosage
;
Gene Expression
;
drug effects
;
Humans
;
Nervous System Diseases
;
drug therapy
;
genetics
;
metabolism
;
Panax notoginseng
;
chemistry
;
Saponins
;
administration & dosage
4.Expression, Mutation, and Deletion of p16 Gene in Gastric Carcinoma
Xiu-Sheng HE ; Qi SU ; Zhu-Chu CHEN ; Xiu-Tao HE ; Shi-You CHE
Chinese Journal of Cancer 2001;20(5):468-473
Objective: This study was designed to investigate the relationship between p16 protein expression and gastric carcinogenesis,depth of invasion, lymph node metastasis, and evaluate the role of deletion and mutation of p16 gene in exon 2 in gastric carcinoma. Methods: p16 protein expression in gastric carcinoma and precancerous lesion was examined by streptavidin-peroxidase conjugated(S-P) method; The deletion and mutation of p16 gene were examined respectively by polymerase chain reaction(PCR) and polymerase chain reaction single-strand conformation polymorphism analysis(PCR-SSCP) in gastric carcinoma. Results: ① The positive rates of p16 protein expression were 96.25% (77/80) in normal gastric mucosa, 92.00% (45/50) in dysplastic gastric mucosa, and 47.54% (58/122) in gastric carcinoma. The positive rate of p16 protein expression in gastric carcinoma was significantly lower than that in normal gastric mucosa and in dysplastic gastric mucosa (P<0.05). ② The positive rate of p16 protein expression in mucoid carcinoma (10.00% ,1/10) was significantly lower than that of poorly differentiated carcinoma (51.22% ,21/41), undifferentiated carcinoma (57.69% ,15/26), and signet ring cell carcinoma (62.50% ,10/16) (P< 0.05). ③ The positive rates of p16 protein in 30 cases paired primary and lymph node metastatic gastric carcinoma were 46.67 % (14/30) in primary gastric carcinoma,16.67% (5/30) in lymph node metastatic gastric carcinoma. The positive rate of lymph node metastatic carcinoma was significantly lower than that of primary carcinoma(P<0.05). ④ Evaluation of mutation and deletion of p16 gene: There was no mutation of p16 gene in exon 2, but there were 5 cases displayed deletion of p16 gene in exon 2 in the 25 primary gastric carcinoma. Conclusions: ① The expression loss of p16 protein is related to carcinogenesis, histopathological subtypes,and lymph metastasis of gastric carcinoma. ② The mutation of p16 gene in exon 2 may not be involved in gastric carcinogenesis. But the deletion of p16 gene in exon 2 might be involved in gastric carcinogenesis.
5.Studies on chemical constituents of aqueous extract of Lonicera japonica flower buds.
Yang YU ; Wei-xia SONG ; Qing-lan GUO ; Sheng LIN ; Su-juan WANG ; Yong-chun YANG ; Jian-gong SHI
China Journal of Chinese Materia Medica 2015;40(17):3496-3504
From an aqueous extract of Lonicera japonica flower buds, sixteen compounds were isolated by a combination of various chromatographic techniques including column chromatography over macroporous resin, MCI gel, silica gel, and sephadex LH-20 and reversed-phase HPLC. Their structures were elucidated by spectroscopic data analysis as 6'-O-acetylvogeloside (1), 6'-O-acetylsecoxyloganin (2), dichlorogelignate (3), guanosinyl-(3' --> 5')-adenosine monophosphate(GpA,4) , 5'-O-methyladenosine (5), 2'-O-methyladenosine (6), adenosine (7), syringin (8), methyl 4-O-β-D-glucopyranosyl caffeate (9), (-)-dihydrophaseic acid 4'-O-β-D-glucopyranoside (10), ketologanin (11), 7α-morroniside (12), 7β-morroniside (13), kingiside (14), cryptochlorogenic acid methyl ester (15), and 6-hydroxymethyl-3-pyridinol (16). All the compounds were obtained from this plant for the first time, compounds 1 and 2 are new compounds, 3 and 5 are new natural products, and 4 is the first example of dinucleoside monophosphate isolated from a plant extract.
Chromatography, High Pressure Liquid
;
Drugs, Chinese Herbal
;
chemistry
;
isolation & purification
;
Flowers
;
chemistry
;
Lonicera
;
chemistry
;
Mass Spectrometry
;
Molecular Structure
6.Distribution of high arsenic drinking water and endemic arsenism in Hubei Province in 2006 and 2007
Ming-jian, LI ; Pei-sheng, XIONG ; Qing, SHI ; Su-hua, ZHOU ; Fang, ZHOU ; Bao-guo, HUANG ; Han-fan, LI
Chinese Journal of Endemiology 2009;28(3):329-331
Objective To confirm the distribution of high arsenic drinking water and the situation of endemic arsenism in Hubei Province, to provide reference basis for prevention and control of endemic arsenic disease. Methods Using typical investigation and sample investigation in 2006 and 2007, the arsenic content of water was detected sampled from 19 counties(cities or communities). And those water samples which were close to or exceeded the stipulated standard were rechecked by the national standard method. Furthermore, the situation of endemic arsenism was investigated in the cities having high arsenic contents of water. Results In 2006,10 028 water samples of 446 villages in 6 counties (cities or communities) were tested, the wells of high arsenic (> 0.05 mg/L) were found in 5 counties (cities or communities) and the proportion of the well that exceeded stipulated standard was 5.29%(530/10 028); In 2007,19 086 water samples of 1282 villages in 17 counties(cities or communities) were tested, the wells of high arsenic were found in 11 counties(cities or communities), and the proportion of the well that exceeded stipulated standard was 1.74%(333/19 086). In these two years, 29 114 water samples were tested, in which 863 water samples were exceeding the stipulated standard. The 2.96% of total wells exceeded stipulated standard and mainly distributed in 179 villages of 12 counties(cities or communities). And the highest arsenic content of water sample was 2.012 mg/L. In the endemic arsenism area, 2 critical, 1 moderate and 1 mild arsenism patients had been found. Conclusions The water of high arsenic content are scattered in Hubei Province and the situation of endemic arsenism disease is mild. Improving water aiming at decreasing arsenic and establishing patient files should be carried out immediately.
8.Effect of IGF-1 on PI3K/PTEN signal pathway in vascular smooth muscle cell.
Xing-li WU ; Ding-you YANG ; Zhong-su YANG ; Shi-wen WANG ; Yu-sheng ZHAO
Chinese Journal of Applied Physiology 2004;20(3):259-262
AIMTo investigate the cellular signal transduction pathway of vascular smooth muscle cell (VSMC) proliferation stimulated by insulin-like growth factor-1 (IGF-1).
METHODSRabbit aortic VSMCs was cultured in 3 groups. Cell proliferating ability was determined by measuring cell number and mitochondrial dehydrogenase (MD) activity (MTT assay). Wortmannin (WT), the specific inhibitor of phosphatidylinositol 3-kinase (PI3K), was used to evaluate indirectly the possible involvement of PI3K. Western blotting was used to detect the protein expression of phosphatase PTEN. Diphosphate action of PTEN on its specific substrate diC16PIP3 was measured by green reagent method.
RESULTSIGF-1 (100 microg/L) increased cell number and MD activity by 2.8-3.8 fold. WT markedly inhibited VSMC proliferation and completely abolished the above effects of IGF-1. IGF-1 inhibited PTEN activity in a concentration-(10-100 microg/L) and time--(3 min-24 h) dependent manner (P < 0.01).
CONCLUSIONIGF-1 increases VSM proliferation by increasing PI3K activity and inhibiting PTEN activity.
Animals ; Cell Line ; Cell Proliferation ; Insulin-Like Growth Factor I ; pharmacology ; Muscle, Smooth, Vascular ; cytology ; Myocytes, Smooth Muscle ; drug effects ; PTEN Phosphohydrolase ; metabolism ; Phosphatidylinositol 3-Kinase ; metabolism ; Phosphorylation ; Rabbits ; Signal Transduction
9.Clinical study of topotecan and cisplatin as first line chemotherapy in epithelial ovarian cancer
Li-Hua MENG ; Bei-Hua KONG ; You-Zhong ZHANG ; Xing-Sheng YANG ; Li-Jie WANG ; Shi-Li SU ; Jie JIANG ; Bao-Xia CUI ; Bo WANG
Chinese Journal of Obstetrics and Gynecology 2000;0(10):-
0.05).(4) Toxicity:Grade Ⅲ-Ⅳ myelosuppression was 60%(18/30)in Tp group,26%(8/31)in TC group and 30%(10/33)in PC group.The TP regimen had the greatest hematologic toxicity(P0.05). Conclusions As first line chemotherapy in epithelial ovarian cancer,TP regimen comparable to the standard chemotherapy regimen.
10.Values of high-frequency ultrasound, elastography and ultrasound contrast in diagnosis of thyroid solid nodules
Ning SHANG ; Hui DU ; sheng Li GUO ; Jun LI ; Na SHI ; yan Su ZHANG ; gui Dou ZHAO
Chinese Medical Equipment Journal 2017;38(9):67-70,77
Objective To investigate the diagnostic criteria of thyroid solid nodules by high-frequency ultrasound,elastography and ultrasound contrast.Methods Totally 87 patients with thyroid solid nodules underwent high-frequency ultrasound,elastography and ultrasound contrast before surgery,distinguishing benign from malignant lesions was executed based on pathological results,and according to the pathological character the image features by the three measures were compared.There were 40 patients divided into a control group going through the examination by high-frequency ultrasound,and 47 ones into an observation group with the examinations by the three measures.Pathological results were used as gold standard,and the two groups were compared on diagnostic sensitivity.Results High-frequency ultrasound showed significant differences of benign and malignant nodules in equal echo,very low echo,irregular peripheral halo,rates of clear nodule boundary and aspect ratio higher than as well as microcalcification (x2--4.603,17.394,5.833,14.832,10.107 and 27.392,and all Pvalues were less than 0.05).There were 85% benign nodules gained grade Ⅰ and Ⅱ elastography images,81.82%malignant nodules had grade Ⅲ and ⅣV elastography images,and there were significant differences between benign and malignant nodules (x2=53.42,P=0.00).Ultrasound contrast found annular enhancement in most of benign nodules (x2=39.16,P<0.01) while uneven enhancement in most of malignant nodules (x2=40.28,P<0.01),and the nodule ranges increasedsignificantly after contrast (t=2.19,P<0.05).The observation group had the sensitivity being 82.86%,which was statisticallyhigher than 59.38% in the control group (x2=4.537,P--0.033).Conclusion High-frequency ultrasound,elastography and ultrasound contrast all show the manifestations of thyroid solid nodules,and the comprehensive application of the above three measures contributes to determining the nature of the nodules.